Revna Biosciences and AstraZeneca Transform Lung Cancer Care in Ghana with Precision Therapy Rollout

The strategic partnership between AstraZeneca and Revna Biosciences is rapidly transforming the landscape of lung cancer care in Ghana. Since the initial...

July 31, 2025 | Thursday | News
Phlow and Antheia Forge Strategic Partnership to Onshore U.S. Pharmaceutical Supply Chains

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient man...

July 30, 2025 | Wednesday | News
Zevra Therapeutics Submits MAA to EMA for Arimoclomol (MIPLYFFA®) in Niemann-Pick Disease Type C

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare ...

July 29, 2025 | Tuesday | News
Inmagene and Ikena Complete $75M Merger to Launch ImageneBio, Inc. on Nasdaq as “IMA”

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA&rdquo...

July 28, 2025 | Monday | News
Sygnature Discovery Doubles High-Throughput Chemistry Capacity with £1M Investment

  Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), today announces the completion of a major enhancemen...

July 24, 2025 | Thursday | News
Cytiva Launches ÄKTA readyflux TFF System 500 to Advance Low-Volume Therapeutic Manufacturing

Cytiva, a Danaher company and a leader in the life sciences industry, is expanding its ÄKTA portfolio with the addition of a system designed to opti...

July 24, 2025 | Thursday | News
New CEO Dr Michael Grosse Charts Confident Course for Sartorius, Backed by Pharma-Focused Expansion

Group sales revenue up 6.1 percent in the first six months As expected, continued positive trend in recurring business with consumables Bioproce...

July 22, 2025 | Tuesday | Company results
Gelteq Partners with IDT Australia to Establish Dedicated Manufacturing Facility for Global Gel-Based Therapeutics

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white ...

July 21, 2025 | Monday | News
Sanofi Completes Acquisition of Blueprint Medicines, Strengthening Rare Immunology Portfolio

Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a p...

July 21, 2025 | Monday | News
EQT Acquires Majority Stake in Adalvo from Aztiq to Fuel Global Expansion

Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in Europe EQT will support Adalvo’s ...

July 21, 2025 | Monday | News
Rare Voices, Real Impact as Alexion Humanises Rare Disease Care

In this BioPharma Boardroom discussion, we speak with Christophe Hotermans, Head of Global Medical Affairs at Alexion, AstraZeneca Rare Disease. From the e...

July 21, 2025 | Monday | Interaction
Ginkgo Bioworks Launches U.S.-Based ADME Profiling Service to Compete with Chinese Vendors on Cost and Scale

Ginkgo Bioworks launches cost-effective, high-throughput ADME profiling service to accelerate small molecule drug discovery with model-ready datasets Gi...

July 18, 2025 | Friday | News
AGC Introduces New Surfactant- and Fluorinated Solvent-Free Grades in AFLAS™ FFKM Series

AGC (AGC Inc., Headquarters: Tokyo; President: Yoshinori Hirai)(TOKYO:5201), a world-leading manufacturer of glass, chemicals and other high-tech materia...

July 18, 2025 | Friday | News
Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield to Expand U.S. Drug Production Capabilities

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additiona...

July 17, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close